. . . . "This unique, single-day conference event unites founding visionary researchers, clinicians, business leaders, key investors, and other stakeholders to engage in discussions, exchange information, highlight opportunities, and showcase leading companies in the field of cancer immunotherapy.Antigen Express is the sponsor of an ongoing Phase II trial of its proprietary AE37 breast cancer vaccine desig" .